Wade Oosterman - 08 Aug 2024 Form 4 Insider Report for CALIX, INC (CALX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Aug 2024, 16:19:18 UTC
Prior SEC filing
14 Jun 2024
Next SEC filing
12 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tom Gemetti as Attorney-in-Fact for Wade Oosterman

Key filing fact

Wade Oosterman filed Form 4 for CALIX, INC (CALX) on 12 Aug 2024.

Key facts

  • This page summarizes Wade Oosterman's Form 4 filing for CALIX, INC (CALX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Aug 2024, 16:19.

Change

  • Previous filing in this sequence was filed on 14 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

(CALX) transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+7,317
Change %
Price
$0.000000
Shares after
7,317
Date
08 Aug 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,317
Exercise price
$37.68
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (August 8, 2025) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .